AT374197B - Verfahren zur herstellung von neuen substituierten 5-(2-imidazolin-2-yl)-aminopyrimidinen und deren saeureadditionssalzen - Google Patents
Verfahren zur herstellung von neuen substituierten 5-(2-imidazolin-2-yl)-aminopyrimidinen und deren saeureadditionssalzenInfo
- Publication number
- AT374197B AT374197B AT0727079A AT727079A AT374197B AT 374197 B AT374197 B AT 374197B AT 0727079 A AT0727079 A AT 0727079A AT 727079 A AT727079 A AT 727079A AT 374197 B AT374197 B AT 374197B
- Authority
- AT
- Austria
- Prior art keywords
- aminopyrimidines
- imidazolin
- acid addition
- addition salts
- producing new
- Prior art date
Links
- -1 2-IMIDAZOLIN-2-YL Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2849537A DE2849537C2 (de) | 1978-11-15 | 1978-11-15 | Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19792937023 DE2937023A1 (de) | 1979-09-13 | 1979-09-13 | Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA727079A ATA727079A (de) | 1983-08-15 |
| AT374197B true AT374197B (de) | 1984-03-26 |
Family
ID=25776489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0727079A AT374197B (de) | 1978-11-15 | 1979-11-14 | Verfahren zur herstellung von neuen substituierten 5-(2-imidazolin-2-yl)-aminopyrimidinen und deren saeureadditionssalzen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4323570A (de) |
| AT (1) | AT374197B (de) |
| AU (1) | AU541305B1 (de) |
| CA (1) | CA1138454A (de) |
| CH (1) | CH642965A5 (de) |
| DK (1) | DK150142C (de) |
| ES (1) | ES486349A1 (de) |
| FR (1) | FR2441625A1 (de) |
| GB (1) | GB2039275B (de) |
| IT (1) | IT1127225B (de) |
| NL (2) | NL190553C (de) |
| SE (1) | SE440079B (de) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2146986B (en) * | 1983-09-23 | 1987-06-17 | Lilly Co Eli | Process for preparing 5-substituted pyrimidines |
| DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
| DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
| DE3904795C2 (de) * | 1989-02-17 | 2000-10-12 | Lilly Pharma Produktion Gmbh & | Pharmazeutisches Präparat und dessen Verwendung |
| US5972948A (en) * | 1994-07-01 | 1999-10-26 | Solvay Pharmaceuticals Gmbh | Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
| DE4423177A1 (de) * | 1994-07-01 | 1996-01-04 | Kali Chemie Pharma Gmbh | Antihyperglykämisch wirksame Arzneimittel |
| US5977121A (en) * | 1995-02-28 | 1999-11-02 | Eli Lilly And Company | Use of moxonidine for the treatment of atherosclerosis |
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
| CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
| EP0914128A1 (de) * | 1996-06-06 | 1999-05-12 | Eli Lilly And Company | Arzneimittel und verfahren zur behandlung des kongestiven herzversagens |
| ZA981029B (en) * | 1997-02-11 | 1999-08-10 | Lilly Co Eli | Pharmaceutical agents. |
| DE19722322A1 (de) * | 1997-05-28 | 1998-12-03 | Solvay Pharm Gmbh | Nephroprotektives Arzneimittel |
| AU9302298A (en) * | 1997-09-03 | 1999-03-22 | Eli Lilly And Company | Pyrimidine derivatives |
| DE19911371A1 (de) | 1999-03-15 | 2000-09-21 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen |
| EP1517688A2 (de) * | 2002-06-19 | 2005-03-30 | Solvay Pharmaceuticals GmbH | Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen |
| EP1981498A2 (de) * | 2006-01-27 | 2008-10-22 | F. Hoffmann-la Roche AG | Verwendung von 2-imidazolen zur behandlung von leiden des zentralen nervensystems |
| ATE411310T1 (de) * | 2006-06-26 | 2008-10-15 | Chemagis Ltd | Reinigungsverfahren von moxonidine |
| EP1894926A1 (de) * | 2006-06-26 | 2008-03-05 | Chemagis Ltd. | Polymorphe von Moxonidine und Verfahren zu deren Herstellung |
| EP1982983B1 (de) | 2006-06-26 | 2011-08-17 | Chemagis Ltd. | Verbessertes Verfahren zur Herstellung von Moxonidin |
| WO2008020425A1 (en) * | 2006-08-17 | 2008-02-21 | Chemagis Ltd. | Crystalline moxonidine comprising single tautomer and preparation process therefor |
| EP1894927B1 (de) * | 2006-08-31 | 2010-11-10 | Chemagis Ltd. | Verwendung der Monoxidinssalze zur Reinigung von Monoxidin |
| CA2666762C (en) * | 2006-10-19 | 2014-12-30 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| WO2008046756A1 (en) * | 2006-10-19 | 2008-04-24 | F. Hoffmann-La Roche Ag | Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| EP2086959B1 (de) * | 2006-11-02 | 2011-11-16 | F. Hoffmann-La Roche AG | Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren |
| MX2009005047A (es) * | 2006-11-16 | 2009-05-25 | Hoffmann La Roche | 4-imidazoles sustituidos. |
| WO2008073125A1 (en) * | 2006-12-12 | 2008-06-19 | Chemagis Ltd. | Moxonidine analogs, preparation processes and uses therefor |
| MX2009005920A (es) * | 2006-12-13 | 2009-06-16 | Hoffmann La Roche | Nuevos 2-imidazoles como ligandos para receptores asociados con trazas de amina. |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| MX2009008255A (es) * | 2007-02-02 | 2009-08-12 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos taar1. |
| KR101222412B1 (ko) * | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ1 리간드로서의 2-아미노옥사졸린 |
| CN101687812A (zh) | 2007-07-02 | 2010-03-31 | 弗·哈夫曼-拉罗切有限公司 | 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物 |
| WO2009003867A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| WO2009016048A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| CN101765425A (zh) * | 2007-08-02 | 2010-06-30 | 弗·哈夫曼-拉罗切有限公司 | 苯甲酰胺衍生物用于治疗cns障碍的用途 |
| BRPI0814758A2 (pt) * | 2007-08-03 | 2015-03-03 | Hoffmann La Roche | Piridinacarboxamida e derivados de benzamida como ligantes taar1 |
| CN102083805A (zh) * | 2008-07-24 | 2011-06-01 | 弗·哈夫曼-拉罗切有限公司 | 4,5-二氢-唑-2-基衍生物 |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| EP2586779A1 (de) | 2011-10-24 | 2013-05-01 | Hetero Research Foundation | Verfahren zur Herstellung von Moxonidine |
| DE102012215896A1 (de) * | 2012-09-07 | 2014-03-13 | Wörwag Pharma GmbH & Co.KG | Moxonidinsynthese mit Hilfe organischer Basen |
| EP2738165B1 (de) | 2012-12-03 | 2016-10-12 | WÖRWAG PHARMA GmbH & Co. KG | Verfahren mittels Phasentransferkatalyse |
| EP2765131B1 (de) | 2013-02-08 | 2016-11-23 | Arevipharma GmbH | Verfahren zur Herstellung von Moxonidin |
| EP2970214A1 (de) * | 2013-03-14 | 2016-01-20 | Farmak, A.S. | Verbessertes verfahren zur herstellung von moxonidin |
| EP2829540A1 (de) | 2013-07-26 | 2015-01-28 | Abbott Healthcare Products B.V. | Synthese von substituierten Aminopyridinen |
| EP3492106B1 (de) | 2013-08-09 | 2021-02-17 | Ardelyx, Inc. | Verbindungen und verfahren zur hemmung eines phosphattransports |
| JP6814814B2 (ja) | 2016-03-17 | 2021-01-20 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｔａａｒのアゴニストとしての活性を有する５−エチル−４−メチル−ピラゾール−３−カルボキサミド誘導体 |
| EP4243826A1 (de) | 2020-11-12 | 2023-09-20 | 3Z Ehf | Neue behandlungen von aufmerksamkeitsdefizit-/hyperaktivitätsstörungen |
| GB202103400D0 (en) * | 2021-03-11 | 2021-04-28 | 3Z Ehf | Novel treatments |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
| GB1319840A (en) * | 1970-08-27 | 1973-06-13 | Beecham Group Ltd | Substituted 5-amino imidazoles |
| BE795636A (fr) * | 1972-02-19 | 1973-08-20 | Schering Ag | Nitroimidazolylpyrimidines, et leur procede de preparation |
| US4029792A (en) * | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
| BE503170A (de) * | 1975-09-02 |
-
1979
- 1979-11-07 US US06/092,134 patent/US4323570A/en not_active Expired - Lifetime
- 1979-11-08 NL NLAANVRAGE7908192,A patent/NL190553C/xx not_active IP Right Cessation
- 1979-11-14 CA CA000339844A patent/CA1138454A/en not_active Expired
- 1979-11-14 DK DK481879A patent/DK150142C/da not_active IP Right Cessation
- 1979-11-14 GB GB7939460A patent/GB2039275B/en not_active Expired
- 1979-11-14 IT IT27284/79A patent/IT1127225B/it active
- 1979-11-14 SE SE7909392A patent/SE440079B/sv not_active IP Right Cessation
- 1979-11-14 AT AT0727079A patent/AT374197B/de not_active IP Right Cessation
- 1979-11-14 ES ES486349A patent/ES486349A1/es not_active Expired
- 1979-11-15 FR FR7928169A patent/FR2441625A1/fr active Granted
- 1979-11-15 CH CH1021679A patent/CH642965A5/de not_active IP Right Cessation
- 1979-11-15 AU AU52873/79A patent/AU541305B1/en not_active Expired
-
1994
- 1994-06-27 NL NL940011C patent/NL940011I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1127225B (it) | 1986-05-21 |
| NL7908192A (nl) | 1980-05-19 |
| GB2039275A (en) | 1980-08-06 |
| AU541305B1 (en) | 1985-01-03 |
| NL940011I2 (nl) | 1998-05-06 |
| FR2441625A1 (fr) | 1980-06-13 |
| GB2039275B (en) | 1982-11-17 |
| ATA727079A (de) | 1983-08-15 |
| CA1138454A (en) | 1982-12-28 |
| CH642965A5 (de) | 1984-05-15 |
| DK150142C (da) | 1987-06-01 |
| SE440079B (sv) | 1985-07-15 |
| ES486349A1 (es) | 1980-06-16 |
| NL190553C (nl) | 1994-04-18 |
| NL190553B (nl) | 1993-11-16 |
| SE7909392L (sv) | 1980-05-16 |
| US4323570A (en) | 1982-04-06 |
| IT7927284A0 (it) | 1979-11-14 |
| FR2441625B1 (de) | 1981-12-31 |
| DK481879A (da) | 1980-05-16 |
| DK150142B (da) | 1986-12-15 |
| NL940011I1 (nl) | 1994-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT374197B (de) | Verfahren zur herstellung von neuen substituierten 5-(2-imidazolin-2-yl)-aminopyrimidinen und deren saeureadditionssalzen | |
| AT373887B (de) | Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen | |
| AT374477B (de) | Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen | |
| AT376666B (de) | Verfahren zur herstellung von neuen diphenylbutyl-diphenylbutylpiperazincarboxamide und -carbothioamiden und deren saeureadditionssalzen | |
| AT373879B (de) | Verfahren zur herstellung von neuen imidazolderivaten und deren salzen | |
| AT362347B (de) | Verfahren zur herstellung von neuen 3-phenoxy-3 -phenylpropanaminen sowie deren saeureadditions- salzen | |
| AT366662B (de) | Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen | |
| AT374188B (de) | Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen | |
| ATA204479A (de) | Verfahren zur herstellung von neuen n-oxacyclyl- alkyl-piperidyl-daizaverbindungen und von deren salzen | |
| AT369731B (de) | Verfahren zur herstellung von neuen 4-pyridon-3-carbonsaeurederivaten und deren salzen | |
| AT376967B (de) | Verfahren zur herstellung von neuen furylverbindungen und von deren salzen | |
| AT368490B (de) | Verfahren zur herstellung von neuen alkylthio-phenoxy-alkylaminen sowie von deren saeureadditionssalzen | |
| AT372081B (de) | Verfahren zur herstellung von neuen substituierten n-iminomethylpiperidinen und von deren saeureadditionssalzen | |
| AT351509B (de) | Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1-phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen | |
| AT367752B (de) | Verfahren zur herstellung von neuen 4-hydroxy-2- benzimidazolin-thion-derivaten und von deren salzen | |
| AT363927B (de) | Verfahren zur herstellung von neuen aniliden und deren ungiftigen saeureadditionssalzen | |
| AT367751B (de) | Verfahren zur herstellung von neuen imidazolderivaten und von deren salzen | |
| ATA144581A (de) | Verfahren zur herstellung von neuen phenylessig- saeure-derivaten und deren salzen | |
| ATA144381A (de) | Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen | |
| ATA144681A (de) | Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen | |
| ATA144781A (de) | Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen | |
| ATA48381A (de) | Verfahren zur herstellung von neuen substituierten 4-sulfonylamino-phenoxyalkancarbonsaeure und deren derivaten | |
| AT377984B (de) | Verfahren zur herstellung von neuen substituierten 4-aryl-2,5-dihydrofuran-2-onen und 4-aryl-1,5- dihydro-2h-pyrrol-2-onen und deren saeureadditionssalzen | |
| ATA305982A (de) | Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen | |
| AT370094B (de) | Verfahren zur herstellung von neuen imidazolderivaten und deren salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EIH | Change in the person of patent owner | ||
| EFA | Change in the company name | ||
| SZA | Application filed for a certificate of protection |
Free format text: SZ06/94, 940829 |
|
| EZF | Grant of a certificate of protection |
Free format text: SZ 6/94, 940829, EXPIRES:20060815 |
|
| EZF | Grant of a certificate of protection |
Free format text: SZ 6/1994, 19940829, EXPIRES:20060815 |
|
| ELA | Expired due to lapse of time |